Liquid biopsy markers for stroke diagnosis

References

• American Stroke Association. Acute and preventive stroke treatments. Available from: https://www.strokeassociation.org
   Google Scholar
• Dreyer R, Murugiah K, Nuti SV, et al. Most important outcomes research papers on stroke and transient ischemic attack. Circulation Cardiovasc Qual Outcomes. 2014;7(1):191–204.
   PubMedGoogle Scholar
• Heart Disease and Stroke Statistics. Update: A report from the American Heart Association. Home Circulation. 2019.
   Google Scholar
• Howard VJ, McClure LA, Glymour MM, et al. Effect of duration and age at exposure to the Stroke Belt on incident stroke in adulthood. Neurology. 2013;80(18):1655–1661.
   PubMed Web of Science ®Google Scholar
• Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(3):870–947.
   PubMed Web of Science ®Google Scholar
• Available from: https://www.stroke.org/en/about-stroke/types-of-stroke/ischemic-stroke-clots
   Google Scholar
• Restarting Antiplatelet Therapy SAFE After Intracerebral Hemorrhage: ERICH Study. [cited 2020 Jun 8]. Available from: https://speciality.medicaldialogues.in/restarting-antiplatelet-therapy-safe-after-intracerebral-hemorrhage-erich-study?infinitescroll=1
   Google Scholar
• Kim BJ, Kang HG, Kim H-J, et al. Magnetic resonance imaging in acute ischemic stroke treatment. J Stroke. 2014;16(3):131.
   PubMed Web of Science ®Google Scholar
• Association AS. Ischemic Stroke (Clots). 2018 [cited 2019 Apr 23]. Available from: https://www.strokeassociation.org/en/about-stroke/types-of-stroke/ischemic-stroke-clots
   Google Scholar
• Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22(9):391–397.
   PubMed Web of Science ®Google Scholar
• Members WG, Lloyd-Jones D, Adams RJ, et al. Executive summary: heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation. 2010;121(7):948–954.
   PubMed Web of Science ®Google Scholar
• Appasamy S, Li W, Lee SH, et al. High-throughput plastic microlenses fabricated using microinjection molding techniques. Opt Eng. 2005;44(12):123401.
   Web of Science ®Google Scholar
• Musuka TD, Wilton SB, Traboulsi M, et al. Diagnosis and management of acute ischemic stroke: speed is critical. CMAJ. 2015;187(12):887–893.
   PubMed Web of Science ®Google Scholar
• Khadilkar S. Neurology: the scenario in India. J Assoc Physicians India. 2012;60:42–44.
   PubMedGoogle Scholar
• Artto V, Putaala J, Strbian D, et al. Stroke mimics and intravenous thrombolysis. Ann Emerg Med. 2012;59(1):27–32.
   PubMed Web of Science ®Google Scholar
• Nau KC, Crocco T, Biola J, et al. Is it stroke, or something else? Rapid response to stroke is crucial, but the rush to treat can endanger patients with conditions that mimic stroke. Here’s how to more readily spot the difference. J Fam Pract. 2010;59(1):26–32.
   PubMedGoogle Scholar
• Guillan M, Alonso-Canovas A, Gonzalez-Valcarcel J, et al. Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features. Cerebrovascular Dis. 2012;34(2):115–120.
   PubMed Web of Science ®Google Scholar
• Gibson L, Whiteley W. The differential diagnosis of suspected stroke: a systematic review. 2013.
   Google Scholar
• Lyden P, Claesson L, Havstad S, et al. Factor analysis of the National Institutes of Health Stroke Scale in patients with large strokes. Arch Neurol. 2004;61(11):1677–1680.
   PubMedGoogle Scholar
• [cited 2019 Apr 23]. Available from: https://www.stroke.nih.gov/documents/NIH_Stroke_Scale_508C.pdf
   Google Scholar
• Nour M, Liebeskind DS. Brain imaging in stroke: insight beyond diagnosis. Neurotherapeutics. 2011;8(3):330–339.
   PubMed Web of Science ®Google Scholar
• Adams HP Jr, Adams RJ, Brott T, et al. Guidelines for the early management of patients with ischemic stroke: a scientific statement from the Stroke Council of the American Stroke Association. stroke. 2003;34(4):1056–1083.
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Seymour J, Cairns J, et al. Immediate computed tomography scanning of acute stroke is cost-effective and improves quality of life. Stroke. 2004;35(11):2477–2483.
   PubMed Web of Science ®Google Scholar
• Morgan CD, Stephens M, Zuckerman SL, et al. Physiologic imaging in acute stroke: patient selection. Interventional Neuroradiol. 2015;21(4):499–510.
   PubMed Web of Science ®Google Scholar
• Lev MH, Farkas J, Gemmete JJ, et al. Acute stroke: improved nonenhanced CT detection—benefits of soft-copy interpretation by using variable window width and center level settings. Radiology. 1999;213(1):150–155.
   PubMed Web of Science ®Google Scholar
• Adams HP Jr, Del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007;115(20):e478–e534.
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Mielke O. Early signs of brain infarction at CT: observer reliability and outcome after thrombolytic treatment—systematic review. Radiology. 2005;235(2):444–453.
   PubMed Web of Science ®Google Scholar
• Oliveira-Filho J, Koroshetz W. Neuroimaging of acute ischemic stroke. Waltham, MA: Wolters Kluwer. UpToDate Retrieved January. 2010.
   Google Scholar
• Amar AP. Brain and vascular imaging of acute stroke. World Neurosurg. 2011;76(6):S3–S8.
   PubMed Web of Science ®Google Scholar
• Sveinsson O, Herrman L, Holmin S. Intra-arterial mechanical thrombectomy: an effective treatment for ischemic stroke caused by endocarditis. Case Rep Neurol. 2016;8(3):229–233.
   PubMed Web of Science ®Google Scholar
• Campbell BC, Weir L, Desmond PM, et al. CT perfusion improves diagnostic accuracy and confidence in acute ischaemic stroke. J Neurol Neurosurg Psychiatry. 2013;84(6):613–618.
   PubMed Web of Science ®Google Scholar
• Berger A. Magnetic resonance imaging. BMJ (Clin Res Ed). 2002;324(7328):35.
   PubMedGoogle Scholar
• Bash S, Villablanca JP, Jahan R, et al. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. Am J Neuroradiol. 2005;26(5):1012–1021.
   PubMed Web of Science ®Google Scholar
• Chalela JA, Kidwell CS, Nentwich LM, et al. Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison. Lancet. 2007;369(9558):293–298.
   PubMed Web of Science ®Google Scholar
• Fung SH, Roccatagliata L, Gonzalez RG, et al. MR diffusion imaging in ischemic stroke. Neuroimaging Clinics. 2011;21(2):345–377.
   PubMed Web of Science ®Google Scholar
• Ginde AA, Foianini A, Renner DM, et al. Availability and quality of computed tomography and magnetic resonance imaging equipment in US emergency departments. Acad Emerg Med. 2008;15(8):780–783.
   PubMed Web of Science ®Google Scholar
• Shen Y-C, Chen G, Hsia RY. Community and hospital factors associated with stroke center certification in the United States, 2009 to 2017. JAMA Network Open. 2019;2(7):e197855–e197855.
   PubMed Web of Science ®Google Scholar
• Wintermark M, Sanelli PC, Albers GW, et al. Imaging recommendations for acute stroke and transient ischemic attack patients: a joint statement by the American Society of Neuroradiology, the American College of Radiology, and the Society of NeuroInterventional Surgery. Am J Neuroradiol. 2013;34(11):E117–E127.
   PubMed Web of Science ®Google Scholar
• Chevilley A, Lesept F, Lenoir S, et al. Impacts of tissue-type plasminogen activator (tPA) on neuronal survival. Front Cell Neurosci. 2015;9:415.
   PubMed Web of Science ®Google Scholar
• Adeoye O, Hornung R, Khatri P, et al. Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. Stroke. 2011;42(7):1952–1955.
   PubMed Web of Science ®Google Scholar
• Investigators CASPR. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology. 2005;64(4):654–659.
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). Jama. 1995;274(13):1017–1025.
   PubMed Web of Science ®Google Scholar
• Wardlaw J, Sandercock P, Berge E. Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis. Stroke. 2003;34(6):1437–1442.
   PubMed Web of Science ®Google Scholar
• Fernández-Monreal M, López-Atalaya JP, Benchenane K, et al. Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling. J Biol Chem. 2004;279(49):50850–50856.
   PubMed Web of Science ®Google Scholar
• Lo EH, Dalkara T, Moskowitz MA. Neurological diseases: mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci. 2003;4(5):399.
   PubMed Web of Science ®Google Scholar
• Haile WB, Wu J, Echeverry R, et al. Tissue-type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF-α. J Cereb Blood Flow Metab. 2012;32(1):57–69.
   PubMed Web of Science ®Google Scholar
• Chamandi C, AAbi-Akar R, Rodés-Cabau J. Transcarotid compared with other alternative access routes for transcatheter aortic valve replacement. Circ Cardiovas Interventions. 2018;11(11):e005362.
   PubMed Web of Science ®Google Scholar
• Guidelines urge new approach to treating worst strokes. 2015. [cited 2019 Apr 23]. Available from: https://www.heart.org/en/news/2018/05/01/guidelines-urge-new-approach-to-treating-worst-strokes
   Google Scholar
• You Z, Ma J, Peach T, et al. Treating intracranial aneurysms—A review of existing and emerging methods☆. Reference module in biomedical sciences. Academic Press: Elsevier; 2017.
   Google Scholar
• Rustenhoven J, Jansson D, Smyth LC, et al. Brain pericytes as mediators of neuroinflammation. Trends Pharmacol Sci. 2017;38(3):291–304.
   PubMed Web of Science ®Google Scholar
• Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis. 2008;32(2):200–219.
   PubMed Web of Science ®Google Scholar
• Papadopoulos C, Saadoun S, Davies DC, et al. Emerging molecular mechanisms of brain tumour oedema. Br J Neurosurg. 2001;15(2):101–108.
   PubMed Web of Science ®Google Scholar
• Tsao N, Hsu H-P, Wu C-M, et al. Tumour necrosis factor-α causes an increase in blood-brain barrier permeability during sepsis. J Med Microbiol. 2001;50(9):812–821.
   PubMed Web of Science ®Google Scholar
• Brouns R, De Deyn P. The complexity of neurobiological processes in acute ischemic stroke. Clin Neurol Neurosurg. 2009;111(6):483–495.
   PubMed Web of Science ®Google Scholar
• Strimbu K, Tavel JA. What are biomarkers? Curr Opin HIV AIDS. 2010;5(6):463.
   PubMed Web of Science ®Google Scholar
• Macias M, Alegre E, Diaz-Lagares A, et al. Liquid biopsy: from basic research to clinical practice. In: Makowski GS, editor. Advances in clinical chemistry, vol 83. Advances in clinical chemistry. Elsevier. Vol. 83. 2018. p. 73–119.
   Google Scholar
• Jefferies SS, Toner M. Liquid biopsy: a perspective for probing blood for cancer. Lab Chip. 2018;18.
   Web of Science ®Google Scholar
• Lalkhen AG, McCluskey A. Clinical tests: sensitivity and specificity. Continuing Educ Anaesth Crit Care Pain. 2008;8(6):221–223.
   Google Scholar
• Pullagurla SR, Baird AE, Adamski MG, et al. Current and future bioanalytical approaches for stroke assessment. Bioanalysis. 2015;7(8):1017–1035.
   PubMed Web of Science ®Google Scholar
• Biomarkers Definitions Working Group: Atkinson AJ Jr, Colburn WA, DeGruttola VG, et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89–95.
   PubMed Web of Science ®Google Scholar
• Craig-Schapiro R, Fagan AM, Holtzman DM. Biomarkers of Alzheimer’s disease. Neurobiol Dis. 2009;35(2):128–140.
   PubMed Web of Science ®Google Scholar
• Kernagis DN, Laskowitz DT. Evolving role of biomarkers in acute cerebrovascular disease. Ann Neurol. 2012;71(3):289–303.
   PubMed Web of Science ®Google Scholar
• Jin R, Yang G, Li G. Molecular insights and therapeutic targets for blood–brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis. 2010;38(3):376–385.
   PubMed Web of Science ®Google Scholar
• Foerch C, Wunderlich MT, Dvorak F, et al. Elevated serum S100B levels indicate a higher risk of hemorrhagic transformation after thrombolytic therapy in acute stroke. Stroke. 2007;38(9):2491–2495.
   PubMed Web of Science ®Google Scholar
• Welsh P, Barber M, Langhorne P, et al. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke. Cerebrovascular Dis. 2009;27(3):247–253.
   PubMed Web of Science ®Google Scholar
• Anderson RE, Hansson L-O, Nilsson O, et al. High serum S100B levels for trauma patients without head injuries. Neurosurgery. 2001;48(6):1255–1260.
   PubMed Web of Science ®Google Scholar
• Allard L, Burkhard PR, Lescuyer P, et al. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin Chem. 2005;51(11):2043–2051.
   PubMed Web of Science ®Google Scholar
• Roberts LJ, Montine TJ, Markesbery WR, et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem. 1998;273(22):13605–13612.
   PubMed Web of Science ®Google Scholar
• Wunderlich MT, Wallesch C-W, Goertler M. Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke. J Neurol Sci. 2004;227(1):49–53.
   PubMed Web of Science ®Google Scholar
• Wunderlich MT, Lins H, Skalej M, et al. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clin Neurol Neurosurg. 2006;108(6):558–563.
   PubMed Web of Science ®Google Scholar
• Dambinova SA, Khounteev GA, Izykenova GA, et al. Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin Chem. 2003;49(10):1752–1762.
   PubMed Web of Science ®Google Scholar
• Bielewicz J, Kurzepa J, Czekajska-Chehab E, et al. Does serum Tau protein predict the outcome of patients with ischemic stroke? J Mol Neurosci. 2011;43(3):241–245.
   PubMed Web of Science ®Google Scholar
• Undén J, Strandberg K, Malm J, et al. Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation. J Neurol. 2009;256(1):72–77.
   PubMed Web of Science ®Google Scholar
• Hjalmarsson C, Bjerke M, Andersson B, et al. Neuronal and glia-related biomarkers in cerebrospinal fluid of patients with acute ischemic stroke. J Cent Nerv Syst Dis. 2014;6(JCNSD):S13821.
   Google Scholar
• Roudbary SA, Saadat F, Forghanparast K, et al. Serum C-reactive proteinSerum C-reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke. Acta Med Iran. 2011;49:149–152.
   PubMedGoogle Scholar
• Shaafi S, Sharifipour E, Rahmanifar R, et al. Interleukin-6, a reliable prognostic factor for ischemic stroke. Iran J Neurol. 2014;13(2):70.
   PubMedGoogle Scholar
• Fang C, Lou B, Zhou J, et al. Blood biomarkers in ischemic stroke: role of biomarkers in differentiation of clinical phenotype. Eur J Inflammation. 2018;16:2058739218780058.
   Web of Science ®Google Scholar
• Lynch JR, Blessing R, White WD, et al. Novel diagnostic test for acute stroke. Stroke. 2004;35(1):57–63.
   PubMed Web of Science ®Google Scholar
• Graham CA, Chan RWY, Chan DYS, et al. Matrix metalloproteinase 9 mRNA: an early prognostic marker for patients with acute stroke. Clin Biochem. 2012 March 1;45(4):352–355.
   PubMed Web of Science ®Google Scholar
• Ulrich NH, Dehmel T, Wittsack HJ, et al. Peripheral blood levels of matrix metalloproteinase-9 predict lesion volume in acute stroke. Neurol Sci. 2013 March 1;34(3):379–382.
   PubMed Web of Science ®Google Scholar
• Tulantched M, Min Z, Feng W-X. Comparison of plasma PARK7 and NDKA diagnostic value in acute stroke. Future Sci OA. 2019;5(5):FSO375.
   Web of Science ®Google Scholar
• Lorente L, Martín MM, Pérez-Cejas A, et al. Association between total antioxidant capacity and mortality in ischemic stroke patients. Ann Intensive Care. 2016;6(1):39.
   PubMedGoogle Scholar
• Inoue T, Ishida T, Inoue T, et al. Lectin-like oxidized low-density lipoprotein receptor-1 levels as a biomarker of acute intracerebral hemorrhage. J Stroke Cerebrovascular Dis. 2019;28(2):490–494.
   PubMed Web of Science ®Google Scholar
• Singh HV, Pandey A, Shrivastava AK, et al. Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit. Clin Chim Acta. 2013;419:136–138.
   PubMed Web of Science ®Google Scholar
• Park S-Y, Kim M-H, Kim O-J, et al. Plasma heart-type fatty acid binding protein level in acute ischemic stroke: comparative analysis with plasma S100B level for diagnosis of stroke and prediction of long-term clinical outcome. Clin Neurol Neurosurg. 2013;115(4):405–410.
   PubMed Web of Science ®Google Scholar
• Dambinova SA, Bettermann K, Glynn T, et al. Diagnostic potential of the NMDA receptor peptide assay for acute ischemic stroke. PloS One. 2012;7(7):e42362.
   PubMed Web of Science ®Google Scholar
• Dharmasaroja P, Dharmasaroja PA, Sobhon P. Increased plasma soluble thrombomodulin levels in cardioembolic stroke. Clin App Thrombosis/Hemostasis. 2012;18(3):289–293.
   PubMed Web of Science ®Google Scholar
• Isenegger J, Meier N, Lämmle B, et al. D-dimers predict stroke subtype when assessed early. Cerebrovascular Dis. 2010;29(1):82–86.
   PubMed Web of Science ®Google Scholar
• Tóth NK, Székely EG, Czuriga-Kovács KR, et al. Elevated factor VIII and von willebrand factor levels predict unfavorable outcome in stroke patients treated with intravenous thrombolysis. Front Neurol. 2018;8:721.
   PubMed Web of Science ®Google Scholar
• Sayan S, Kotan D. Levels of brain natriuretic peptide as a marker for the diagnosis and prognosis of acute ischemic stroke. Arch Med Sci Atherosclerotic Dis. 2016;1(1):e16.
   PubMedGoogle Scholar
• Bustamante A, López-Cancio E, Pich S, et al. Blood biomarkers for the early diagnosis of stroke. Stroke. 2017;48(9):2419–2425.
   PubMed Web of Science ®Google Scholar
• Cucchiara BL, Messe SR, Sansing L, et al. Lipoprotein-associated phospholipase A2 and C-reactive protein for risk-stratification of patients with TIA. Stroke. 2009;40(7):2332–2336.
   PubMed Web of Science ®Google Scholar
• Ovbiagele B, Starkman S, Teal P, et al. Serum calcium as prognosticator in ischemic stroke. Stroke. 2008;39(8):2231–2236.
   PubMed Web of Science ®Google Scholar
• Worthmann H, Chen S, Martens-Lobenhoffer J, et al. High plasma dimethylarginine levels are associated with adverse clinical outcome after stroke. J Atheroscler Thromb. 2011;18(9):753–761.
   PubMed Web of Science ®Google Scholar
• Ren C, Kobeissy F, Alawieh A, et al. Assessment of serum UCH-L1 and GFAP in acute stroke patients. Sci Rep. 2016 April 14;6(1):24588.
   PubMedGoogle Scholar
• De Marchis GM, Katan M, Weck A, et al. Copeptin adds prognostic information after ischemic stroke. Results CoRisk Stud. 2013;80(14):1278–1286.
   Google Scholar
• Bustamante A, Mancha F, Macher HC, et al. Circulating cell-free DNA is a predictor of short-term neurological outcome in stroke patients treated with intravenous thrombolysis. J Circ Biomark. 2016;5:1849454416668791.
   Google Scholar
• Vajpeyee A, Wijatmiko T, Vajpeyee M, et al. Cell free DNA: A novel predictor of neurological outcome after intravenous thrombolysis and/or mechanical thrombectomy in acute ischemic stroke patients. Neurointervention. 2018;13(1):13–19.
   PubMedGoogle Scholar
• Regner A, Meirelles L, Ikuta N, et al. Prognostic utility of circulating nucleic acids in acute brain injuries. Expert Rev Mol Diagn. 2018 November 2;18(11):925–938.
   PubMed Web of Science ®Google Scholar
• Olivot J-M, Labreuche J, Aiach M, et al. Soluble thrombomodulin and brain infarction: case-control and prospective study. Stroke. 2004;35(8):1946–1951.
   PubMed Web of Science ®Google Scholar
• Ribo M, Montaner J, Molina CA, et al. Admission fibrinolytic profile is associated with symptomatic hemorrhagic transformation in stroke patients treated with tissue plasminogen activator. Stroke. 2004;35(9):2123–2127.
   PubMed Web of Science ®Google Scholar
• Pikula A, Böger RH, Beiser AS, et al. Association of plasma ADMA levels with MRI markers of vascular brain injury: framingham offspring study. Stroke. 2009;40(9):2959–2964.
   PubMed Web of Science ®Google Scholar
• Sibal L, Agarwal SC, Home PD, et al. The Role of Asymmetric Dimethylarginine (ADMA) in endothelial dysfunction and cardiovascular disease. Curr Cardiol Rev. 2010;6(2):82–90.
   PubMedGoogle Scholar
• Makikallio A, Makikallio T, Korpelainen J, et al. Natriuretic peptides and mortality after stroke. Stroke. 2005;36(5):1016–1020.
   PubMed Web of Science ®Google Scholar
• Gorelick PB. Lipoprotein-associated phospholipase A2 and risk of stroke. Am J Cardiol. 2008;101(12):S34–S40.
   Google Scholar
• Huang P, Lo L-H, Chen Y-C, et al. Serum free hemoglobin as a novel potential biomarker for acute ischemic stroke. J Neurol. 2009;256(4):625.
   PubMed Web of Science ®Google Scholar
• Bhaskaran M, Mohan M. MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet Pathol. 2014;51(4):759–774.
   PubMed Web of Science ®Google Scholar
• Jickling GC, Ander BP, Zhan X, et al. microRNA expression in peripheral blood cells following acute ischemic stroke and their predicted gene targets. PloS One. 2014;9(6):e99283.
   PubMed Web of Science ®Google Scholar
• Moore DF, Li H, Jeffries N, et al. Using peripheral blood mononuclear cells to determine a gene expression profile of acute ischemic stroke: a pilot investigation. Circulation. 2005;111(2):212–221.
   PubMed Web of Science ®Google Scholar
• Tang Y, Xu H, Du XL, et al. Gene expression in blood changes rapidly in neutrophils and monocytes after ischemic stroke in humans: a microarray study. J Cereb Blood Flow Metab. 2006;26(8):1089–1102.
   PubMed Web of Science ®Google Scholar
• Barr T, Conley Y, Ding J, et al. Genomic biomarkers and cellular pathways of ischemic stroke by RNA gene expression profiling. Neurology. 2010;75(11):1009–1014.
   PubMed Web of Science ®Google Scholar
• Baird AE, Moore DF, Goldin E, et al. Differential expression of molecules associated with intra-cerebral hemorrhage. Google Patents. 2010.
   Google Scholar
• Adamski MG, Li Y, Wagner E, et al. CD15+ granulocyte and CD8+ T lymphocyte based gene expression clusters for ischemic stroke detection. Med Res Arch. 2017;5(11).
   Google Scholar
• Pullagurla SR, Witek MA, Jackson JM, et al. Parallel affinity-based isolation of leukocyte subsets using microfluidics: application for stroke diagnosis. Anal Chem. 2014;86(8):4058–4065.
   PubMed Web of Science ®Google Scholar
• Baird AE. Blood biologic markers of stroke: improved management, reduced cost? Curr Atheroscler Rep. 2006;8(4):267–275.
   PubMedGoogle Scholar
• Baird AE, Soper SA, Pullagurla SR, et al. Recent and near-future advances in nucleic acid-based diagnosis of stroke. Expert Rev Mol Diagn. 2015;15(5):665–679.
   PubMed Web of Science ®Google Scholar
• Kalafut MA, Schriger DL, Saver JL, et al. Detection of early CT signs of> 1/3 middle cerebral artery infarctions: interrater reliability and sensitivity of CT interpretation by physicians involved in acute stroke care. Stroke. 2000;31(7):1667–1671.
   PubMed Web of Science ®Google Scholar
• Hill MD. What kind of stroke is it? Clin Chem. 2008;54(12):1943–1944.
   PubMed Web of Science ®Google Scholar
• Fonarow GC, Zhao X, Smith EE, et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. Jama. 2014;311(16):1632–1640.
   PubMed Web of Science ®Google Scholar
• Kim JY, Park J, Chang JY, et al. Inflammation after ischemic stroke: the role of leukocytes and glial cells. Exp Neurobiol. 2016;25(5):241–251.
   PubMed Web of Science ®Google Scholar
• Jeffrey SS, Toner M. Liquid biopsy: a perspective for probing blood for cancer. Lab Chip. 2019;19(4):548–549.
   PubMed Web of Science ®Google Scholar
• Zaborowski MP, Balaj L, Breakefield XO, et al. Extracellular vesicles: composition, biological relevance, and methods of study. Bioscience. 2015;65(8):783–797.
   PubMed Web of Science ®Google Scholar
• Yoon YJ, Kim OY, Gho YS. Extracellular vesicles as emerging intercellular communicasomes. BMB Rep. 2014;47(10):531.
   PubMed Web of Science ®Google Scholar
• Chen CC, Liu L, Ma F, et al. Elucidation of exosome migration across the blood–brain barrier model in vitro. Cell Mol Bioeng. 2016;9(4):509–529.
   PubMed Web of Science ®Google Scholar
• Matsumoto J, Stewart T, Banks WA, et al. The transport mechanism of extracellular vesicles at the blood-brain barrier. Curr Pharm Des. 2017;23(40):6206–6214.
   PubMed Web of Science ®Google Scholar